Cynthia Kenyon’s biography, net worth, fact, career, awards and life story

Intro American molecular biologist
A.K.A. Cynthia Jane Kenyon
Is Scientist 
Biologist 
Physicist 
Biophysicist 
Geneticist 
Molecular biologist 
From United States of America 
Type Biology 
Science 
Gender female
Birth 21 February 1954, Chicago, Cook County, Illinois, U.S.A.
Age: 66 years

Cynthia Jane Kenyon (February 21, 1954) is an American molecular biologist and biogerontologist known for her genetic dissection of aging in a widely used model organism, the roundworm Caenorhabditis elegans and professor at the University of California, San Francisco (UCSF).

Career

Cynthia Kenyon graduated valedictorian in chemistry and biochemistry from the University of Georgia in 1976. She received her PhD in 1981 from MIT where, in Graham Walker’s laboratory, she looked for genes on the basis of their activity profiles, discovering that DNA-damaging agents activate a battery of DNA repair genes in E. coli. She then did postdoctoral studies with Nobel laureate Sydney Brenner at the MRC Laboratory of Molecular Biology in Cambridge, England, studying the development of C. elegans.

Since 1986 she has been at the University of California, San Francisco (UCSF), where she was the Herbert Boyer Distinguished Professor of Biochemistry and Biophysics and is now an American Cancer Society Professor. In 1999 she co-founded Elixir Pharmaceuticals with Leonard Guarente to try to discover and develop drugs that would slow down the process that makes people age.

In April 2014, Kenyon was named Vice President of Aging Research at Calico, a new company focused on health, well-being, and longevity. Prior to that, she served as a part-time advisor beginning in November 2013. Kenyon will remain affiliated with UCSF as an emeritus professor.

Her early work led to the discovery that Hox genes, which were known to pattern the body segments of the fruit fly (Drosophila) also pattern the body of C. elegans. These findings demonstrated that Hox genes were not simply involved in segmentation, as thought, but instead were part of a much more ancient and fundamental metazoan patterning system.

Michael Klass discovered that lifespan of C. elegans could be altered by mutations, but Klass believed that the effect was due to reduced food consumption (caloric restriction). Thomas Johnson later showed that the 65% life extension effect was due to the mutation itself rather than due to caloric restriction. In 1993, Kenyon’s discovery that a single-gene mutation (Daf-2) could double the lifespan of C. elegans and that this could be reversed by a second mutation in daf-16m, sparked an intensive study of the molecular biology of aging, including work by Leonard Guarente and David Sinclair. Kenyon’s findings have led to the discovery that an evolutionarily-conserved hormone signaling system influences aging in other organisms, perhaps also including mammals.

Kenyon has received many honors, including the King Faisal Prize for Medicine, the American Association of Medical Colleges Award for Distinguished Research, the Ilse & Helmut Wachter Award for Exceptional Scientific Achievement, and La Fondation IPSEN Prize, for her findings. She is a member of the U.S. National Academy of Sciences and the American Academy of Arts and Sciences. She was President of the Genetics Society of America for 2003. She is also one of featured biologists in the 1995 science documentary Death by Design / The Life and Times of Life and Times.

  • I. & H. Wachter Award, I. & H. Wachter Foundation (2005)

Personal diet

Kenyon’s research prompted her to make personal dietary changes.

In 2000, when she discovered that putting sugar on the worms’ food shortened their lifespans, she stopped eating high glycemic index carbohydrates and started eating a low-carbohydrate diet.

She briefly experimented with a calorie restriction diet for two days, but couldn’t stand the constant hunger.

You May Also Like

Kimbra’s net worth, biography, fact, career, awards and life story

Kimbra Net Worth: Kimbra is a New Zealand recording artist who has a net worth of $3 million. Kimbra Lee Johnson was born in Hamilton, New Zealand in March 1990. She started writing songs at the age of 10 and her father bought her a guitar at 12. She won 2nd place at the 2004 Rockquest competition. She won a Juice TV award for Best Breakthrough music video in 2007. In 2011 Kimbra’s debut studio album Vows was released. The album was certified Platinum in Australia and New Zealand. It reached #4 on the Australian charts, #3 in New Zealand, and #14 in the United States. The album contained the singles “Settle Down”, “Good Intent”, and “Warrior”. Vows was released in 2012 in the United States and Europe. In 2011 Kimbra was featured on Gotye’s hit single “Somebody That I Used to Know”. The single was certified 11x Platinum and reached #1 in Australia, Austria, Belgium, Canada, Germany, Ireland, New Zealand, the U.K., and the U.S. The pair won Grammy Awards for Record of the Year and Best Pop Duo/Group Performance at the 55th Annual Grammy Awards in 2013. Kimbra became just the third singer from New Zealand to win a Grammy Award. Her second album The Golden Echo is scheduled to be released in 2014 and features the single “90’s Music”. As a solo artist Kimbra has won two ARIA Awards, six New Zealand Music Award, and a Rolling Stone Award.
Read More